OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

TRACE-I: Long-Term Outcomes of PSMA-Guided Salvage Surgery in Recurrent Prostate Cancer

Can Maintenance HER2 Therapy Be Stopped? Global Survey Reveals Clinical Equipoise in Long-Term Responders

Melvin L.K. Chua: Defining Where Proton Beam Therapy Benefits Nasopharyngeal Carcinoma

Can Distant Lymph Nodes Sustain Immunotherapy After Lymph-Node Surgery?

Miriam Mutebi: What Does Resilience Really Mean for Women Navigating Our Healthcare Systems?

Oncology News, Insights, Stories by OncoDaily

Matti Aapro
Societies

Two OncoDaily Mentors, One Global Mission: Matti Aapro and Hesham Elghazaly Run for UICC Board

Pope Leo XIV Lung Cancer Diagnosis: Surgery, Prognosis and Survival Rates
Celebrities and Cancer

Pope Leo XIV Lung Cancer Diagnosis: Surgery, Prognosis and Survival Rates

OncoDaily Academy
OncoDaily Pulse

OncoDaily Academy Introduces the First Module of its Six-part Programme on Immune Checkpoint Inhibitors

AENEAS2: Aumolertinib Plus Chemotherapy Extends PFS in EGFR-Mutant Advanced NSCLC

American Cancer Society Journals Highlights Personalized Physical Activity for Young Cancer Survivors

Matthew Kurian: $2 Billion Bet on the Future of Oncology

Deb Schrag: New Research Highlights Opportunities for Germline Risk Detection Across Cancer Patients

First European Cancer Literacy Day

ESTRO and ASTRO-Endorsed Recommendations Address Rectal Cancer Reirradiation

ESMO 2026 Survival Guide for Advocates: Science, Spanish, Stickers and a Little Madrid Magic

Voices
Mohammed Ibrahim

Mohammed Ibrahim։ Tsinat Breast Cancer Support Group Brings Women Together to Share Support, Hope, and Strength

Anthony Letai: NCI Officially Awarded and Fully Delivered All Grant Funding for Fiscal Year 2026

The Molecular Characterization Initiative Surpassed 10,000 Patients Enrolled! - NCI

Emad Shash: Redefining the Oncology Pharmacist’s Role in Modern Breast Cancer Care

Richard Tillyer: Translating Promising Research Into Potential New Options for Patients at Johnson & Johnson

Christopher Jackson: Humbled and Honoured to Receive the HRC’s Beaven Medal

Timothy Rebbeck: The Goal Is Better Health for Children and Adults Across Uzbekistan

FDA Approvals
CLL/SLL Pirtobrutinib

FDA Approves Pirtobrutinib for First-Line CLL/SLL Without 17p Deletion, a First for Non-Covalent BTK Inhibitors

Teva Receives U.S. FDA Approval for Denosumab Biosimilar for Oncology Indications

Niklas Klümper: FDA Approves Belzutifan Plus Lenvatinib in Advanced ccRCC

FDA Approves Imlunestrant Plus Abemaciclib for ESR1-Mutated Advanced Breast Cancer

FDA Approves Taletrectinib Label Update With 49.7-Month Duration of Response in ROS1+ NSCLC

FDA Approves Curium’s Bexlutry (Lutetium Lu 177) for SSTR-Positive Gastroenteropancreatic Neuroendocrine Tumors

FDA Approves Floretyrosine F 18 for PET Imaging in Glioma

OncoDaily 100
100 Influential Women

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

Celebrities and Cancer

OncoCalendar

ESSO Advanced Course on the Treatment of Peritoneal Surface Malignancy

European Society of Surgical Oncology

15 Oct
Peritoneal Surface Malignancy

ESSO Hands-on Course on Minimally Invasive Oesophagectomy and Gastrectomy

European Society of Surgical Oncology

15 Oct
Oesophagectomy and Gastrectomy

28th Annual Blood-Brain Barrier Consortium

Providence Neuroscience Institute

15 Oct
Blood-Brain Barrier

JADPRO Live 2026

Advanced Practitioner Society for Hematology and Oncology (APSHO)

15 Oct
JADPRO

The 17th AFSOS National Congress of Supportive Oncology Care

Association Francophone des Soins Oncologiques de Support (AFSOS)

15 Oct
AFSOS National Congress

Advancing Pediatric Liver Tumor Care: Bridging Global Standards and Asia-Pacific Practice

International Society of Paediatric Oncology (SIOP)

15 Oct
Pediatric Liver Tumor

ASCO Quality Care Symposium 2026

American Society of Clinical Oncology

16 Oct
ASCO

16th Biennial Rivkin Ovarian Cancer Research Symposium

Ovarian Cancer Research Alliance

16 Oct
Ovarian Cancer Research Symposium

Benign Hematology and Thrombosis: 2026 Emerging Therapies - MSK

Memorial Sloan Kettering Cancer Center (MSK)

16 Oct
Benign Hematology

OPN Southwest Chapter Conference 2026

Oncology Pharmacy Network

17 Oct
OPN Southwest Chapter Conference

2026 WAHO and WON Advancing Oncology Together

Wisconsin Association of Hematology and Oncology (WAHO)

17 Oct
Advancing Oncology Together

19th AACR Conference on The Science of Cancer Health Disparities

American Association for Cancer Research

18 Oct
Cancer Health Disparities

Immune-oncology
Can Distant Lymph Nodes Sustain Immunotherapy After Lymph-Node Surgery?

Can Distant Lymph Nodes Sustain Immunotherapy After Lymph-Node Surgery?

BioNTech Shares Update on Phase 2/3 Clinical Trial for mRNA Cancer Immunotherapy in Metastatic HPV16-Positive HNC

DECIDE-MET Trial: Targeted Therapy or Immunotherapy First in METex14 NSCLC?

KEYNOTE-B49 at ESMO 2026: Can Immunotherapy Find a Role in HR+/HER2− Breast Cancer?

INMC Analysis: Can Pathological Response Guide Treatment in Melanoma?

Nivolumab/Ipilimumab and Pembrolizumab for All Cancers: Australia Expands Immunotherapy Access

The Tumor Microenvironment and Immune Escape: Mechanisms and Therapeutic Implications

Gastrointestinal-Oncology
FFCD-AC

FFCD-AC: 1L Chemotherapy for Metastatic Recurrence of Ampullary Adenocarcinoma

Phase 3b SIERRA: Durvalumab Plus Tremelimumab in Poor-Prognosis Unresectable HCC

Phase 1b/2 HERBOT Trial: First-Line HER2-Targeted Chemoimmunotherapy in Biliary Tract Cancer

10 Must-Read Posts In GI Oncology This Week

9 Hepatobiliary Cancer Trials to Watch at ESMO 2026

Armenia Grants World's First Marketing Authorizations for BOT+BAL in MSS mCRC

FDA Approved Atezolizumab Plus Chemotherapy for Stage III dMMR Colon Cancer

Breast-Oncology
MAMMÔ 2026

MAMMÔ 2026: Precision, De-Escalation and New Treatment Sequencing Reshape Breast Cancer Care

Can Maintenance HER2 Therapy Be Stopped? Global Survey Reveals Clinical Equipoise in Long-Term Responders

NRG-BR002: Metastasis-Directed Ablation Fails to Improve PFS or OS in Oligometastatic Breast Cancer

Risk-Adapted Approach to Neoadjuvant Therapy in HER2-Positive Early Breast Cancer

How Systemic Therapy Is Reshaping Breast Cancer Care in 2026

HER2-Positive Breast Cancer in 2026: The New Goal Is Not More Treatment, but the Right Treatment

Datopotamab Deruxtecan Approved in China for Advanced Triple-Negative Breast Cancer

Lung-Oncology
Jazz EMERGE 402

Jazz EMERGE 402: Real-World Lurbinectedin Shows Clinically Meaningful Activity in Previously Treated SCLC

AENEAS2: Aumolertinib Plus Chemotherapy Extends PFS in EGFR-Mutant Advanced NSCLC

Unresectable Stage III NSCLC: PACIFIC Remains the Backbone as Precision Strategies Reshape Care

Hong Kong Model Finds EGFR/ALK-First Testing More Cost-Efficient Than Upfront NGS in Metastatic NSCLC

Small-Molecule Inhibitors in NSCLC: A 2026 Practical Guide to Drug Interactions and Toxicity

AMAZE-lung Trial: Triple Targeting With Amivantamab, Lazertinib and Bevacizumab in EGFR-Mutant NSCLC

Asian Patients Showed Longer Survival With Atezolizumab-Chemotherapy in Pooled ES-SCLC Analysis

OncoDaily TV
Dr Gevorg Tamamyan

“Stronger Regions, Stronger Countries…” – Dr Gevorg Tamamyan

Rejin Kebudi

“Diligent, Intelligent, Capable of Reaching Many Colleagues Globally ” – Rejin Kebudi, General Secretary of the International Society of Pediatric Oncology, about Dr Gevorg Tamamyan Upon His WHO DG Candidacy

Dr. Gevorg Tamamyan

“One of the Most Amazing and Truly Legendary Oncologists of Our Time” – Dr. Gevorg Tamamyan on Dr. Julie Gralow, Chief Medical Officer of ASCO

Dr Gevorg Tamamyan

“I Still Remember His Mentees That Spoke So Highly of Him… Having a Vision Means Investing in People That Will Make a Difference For the Years to Come” – Albanian Hematologist Liri Seraj Supports Dr Gevorg Tamamyan as WHO DG Candidate

World Radiotherapy Awareness Day

12 Countries, One Vision for the Future of Radiotherapy – World Radiotherapy Awareness Day

Bishal Gyawali

Erika Ruiz-Garcia Joins Bishal Gyawali on Grounded In Groundshot Podcast

Dr Gevorg Tamamyan

“One Planet is Not Enough For His Vision” – Dr Amalya Sargsyan Celebrates Her Mentor Dr Gevorg Tamamyan

Dr Gevorg Tamamyan

Renowned Surgeon and Inventor of Abraxane, Philanthropist Dr Patrick Soon-Shiong Endorses Dr Gevorg Tamamyan as WHO Director-General Candidate

Burnout

Oncology Beyond Guidelines: Burnout, Imposter Syndrome, Mentorship & Cancer Prevention with Imène Hadji

Holistic Healing

Cancer Survivorship, Holistic Healing and Patient Advocacy with Rohini Singh Sisodia

ONCOFFEE

ONCOFFEE: Cancer Care in Nepal, Global Oncology, and Bridging Resource Gaps with Vivek Ghosh

The CML Evolution

The CML Evolution: Mastering Modern Algorithms in Chronic Myeloid Leukemia

Not To Miss
Merck

Merck at ESMO 2026: Phase 3 mRNA, TROP2 ADC and Pembrolizumab Data Lead 90+ Abstracts

RYZ101 Improves PFS in Phase 3 ACTION-1 Trial for GEP-NETs After Lutetium-177 Therapy

15 Posts Not To Miss From DCLung26

Over 30,000 People Join Breast Care International Walk for Greater Rural Breast Cancer Awareness in Ghana

From Liquid Biopsy to New Treatment Modalities: What to Expect at Northeast GI Oncology Congress 2026

OCRF and News Corp Australia Launch "Over It" Campaign to Close the Ovarian Cancer Survival Gap

Oncopeptides Reports Blood-Brain Barrier Penetration in Glioblastoma INSULA Study

OncoGrants
Clinical Accelerator Initiative 2026

Lustgarten Foundation Dr. Robert F. Vizza Clinical Accelerator Initiative 2026

Melanoma Research

Melanoma Research Alliance Young Investigator Award 2026–2027

Gilead Research Scholars Program

Gilead Research Scholars Program in Solid Tumors 2026

Lung Cancer Canada

Lung Cancer Canada Breathe Forward Award: $200,000 for NSCLC Diagnostic Innovation

Cancer Detection

NCI Pancreatic Cancer Detection Consortium: Research Units

Clinical Innovator Grant

CRI Clinical Innovator Grant 2026–2027

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
Non-Hodgkin Lymphoma NHL, DLBCL

Non-Hodgkin Lymphoma (NHL): A Practical Biological Map and Integrative Overview

Mantle Cell Lymphoma (MCL): Revealing the Biology Beneath the Mantle and Modern Therapeutic Frontiers

Burkitt Lymphoma: Among the Fastest Growing Yet Most Curable Human Cancers

Diffuse Large B-Cell Lymphoma (DLBCL): Molecular Heterogeneity and Progress in Therapy

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Current Perspectives on an Ultra-Rare Malignancy

Richter Transformation (RT): When Chronic Lymphocytic Leukemia Turns Aggressive

Acute Myeloid Leukemia (AML) in 2026: Current Practice and Evolving Directions

CancerWorld

Oncologists
Gabriëlle van Ramshorst

Gabriëlle van Ramshorst

Oncologists Location Ghent, Belgium
Yuman Fong

Yuman Fong

Oncologists Location Duarte, USA
Wade Swenson

Wade Swenson

Oncologists Location Staples, USA
Tetiana Shevchuk

Tetiana Shevchuk

Oncologists Location Kyiv, Ukraine
Chi-kong Li

Li Chi-kong

Oncologists Location Hong Kong, China
Assia Konsoulova

Assia Konsoulova

Oncologists Location Sofia, Bulgaria
Philip Kantoff

Philip Kantoff

Oncologists Location Boston, USA
Alexandra Müller

Alexandra Müller

Oncologists Location Freiburg, Germany

Oncology Drugs
OTX-2002: Innovative MYC-Targeting mRNA Therapy, Dose, Administration, and Clinical Trials

OTX-2002: Innovative MYC-Targeting mRNA Therapy, Dose, Administration, and Clinical Trials

mRNA-4359: Promising Cancer Vaccine, Dose, Administration, and Clinical Trials

BXCL701: Promising Innate Immune Activation, Dose, Administration, And Clinical Trials

NBTXR3: Promising Radioenhancer, Administration, Dose, And Clinical Trials

KT-333: Promising STAT3 Degradation, Dose, Administration, And Clinical Trials

Veliparib: Mechanism, Dose, Administration, And Clinical Trials

Adavosertib: Mechanism, Dose, Administration, And Clinical Trials

OncoDaily Magazine

New Paper Alert
Lana Kandalaft

Lana Kandalaft: Transforming Therapeutic Cancer Vaccine Strategies for Pancreatic Cancer

American Cancer Society Journals

American Cancer Society Journals Highlights Personalized Physical Activity for Young Cancer Survivors

Anthony Letai

Anthony Letai: A New Oral Combination for Advanced Breast Cancer

Diego Díaz-García

Diego Díaz García: AENEAS2 Explores Treatment Sequencing in EGFR-Mutated NSCLC

Xenofon Vakalis

Xenofon Vakalis: A New Step in HER2+ Metastatic Breast Cancer - But Is It Practice-Changing?

Ahmed Orabi

Ahmed Orabi: Chest Wall Perforator Flaps Offer New Options for Breast Reconstruction

OncoDaily Medical Journal

Breast Cancer

10.69690/ODMJ-001-1026-8231

Variable-Volume Oncoplastic Reconstruction Using a Modified Würinger Central Pedicle Technique for Upper Quadrants Breast Cancer: a single-center experience
Original Research

GI Oncology

10.69690/ODMJ-001-1026-8138

Association of Alpha-Fetoprotein and Clinical Outcomes in Patients with Unresectable Hepatocellular Carcinoma Treated with First-Line Camrelizumab Plus Rivoceranib vs Sorafenib: Post Hoc Exploratory Analysis of the CARES-310 Trial
Original Research

Oncology Nursing

10.69690/ODMJ-002-0926-8087

Risk of Atrial Fibrillation in Breast Cancer Patients Treated with Radiotherapy: A Scoping Review
Reviews

Pediatric Oncology

10.69690/ODMJ-011-0826-7849

Integrated Management of Endo and Exo-pelvic Sacrococcygeal Teratomas (Altman type III): Report of Two Cases
Case Reports & Case Series

Oncology Nursing

10.69690/ODMJ-001-0826-7778

Real-World Patterns of Immune-Related Toxicity in Gastrointestinal Cancer Patients Treated with Immunotherapy: A service evaluation
Original Research

Oncology Nursing

10.69690/ODMJ-002-0826-7795

Late presentation in cancer care: Implications for treatment and survival: A Narrative Review
Reviews

GI Oncology

10.69690/ODMJ-018-0826-7959

From Plate to Polyps: Dietary N-Nitrosamines and Biomarkers of DNA Damage
Abstracts

Head and Neck Cancer

10.69690/ODMJ-018-0826-7933

A Service Review of PD-L1 Biomarker Use in the Head and Neck Cancer Service
Abstracts